ATE530671T1 - Verbindungen und verfahren zur diagnose von tuberkulose - Google Patents

Verbindungen und verfahren zur diagnose von tuberkulose

Info

Publication number
ATE530671T1
ATE530671T1 AT09174756T AT09174756T ATE530671T1 AT E530671 T1 ATE530671 T1 AT E530671T1 AT 09174756 T AT09174756 T AT 09174756T AT 09174756 T AT09174756 T AT 09174756T AT E530671 T1 ATE530671 T1 AT E530671T1
Authority
AT
Austria
Prior art keywords
tuberculosis
polypeptides
compounds
methods
diagnosis
Prior art date
Application number
AT09174756T
Other languages
English (en)
Inventor
Steven Reed
Yasir Skeiky
Davin Dillon
Antonio Campos-Neto
Raymond Houghton
Thomas Vedvick
Daniel Twardzik
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27541833&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE530671(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE530671T1 publication Critical patent/ATE530671T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
AT09174756T 1995-09-01 1996-08-30 Verbindungen und verfahren zur diagnose von tuberkulose ATE530671T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52343595A 1995-09-01 1995-09-01
US53213695A 1995-09-22 1995-09-22
US62028096A 1996-03-22 1996-03-22
US65880096A 1996-06-05 1996-06-05
US68057396A 1996-07-12 1996-07-12

Publications (1)

Publication Number Publication Date
ATE530671T1 true ATE530671T1 (de) 2011-11-15

Family

ID=27541833

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09174756T ATE530671T1 (de) 1995-09-01 1996-08-30 Verbindungen und verfahren zur diagnose von tuberkulose
AT96933010T ATE324445T1 (de) 1995-09-01 1996-08-30 Verbindungen und verfahren zur diagnose von tuberkulose

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96933010T ATE324445T1 (de) 1995-09-01 1996-08-30 Verbindungen und verfahren zur diagnose von tuberkulose

Country Status (13)

Country Link
EP (2) EP2154248B1 (de)
JP (1) JPH11514217A (de)
CN (2) CN1154730C (de)
AT (2) ATE530671T1 (de)
AU (1) AU7158796A (de)
CA (1) CA2230927A1 (de)
CY (1) CY2618B2 (de)
DE (1) DE69636075D1 (de)
DK (1) DK2154248T3 (de)
ES (1) ES2378051T3 (de)
MX (1) MX9801687A (de)
PT (1) PT2154248E (de)
WO (1) WO1997009429A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
JP2001500383A (ja) * 1996-10-11 2001-01-16 コリックサ コーポレーション 結核診断用の化合物および方法
US6350456B1 (en) 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
JP4172598B2 (ja) * 1997-04-02 2008-10-29 スタテンス セールム インスティトゥート 結核菌由来の核酸フラグメント及びポリペプチドフラグメント
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US6555653B2 (en) 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
US6436409B1 (en) * 1997-07-16 2002-08-20 Institut Pasteur Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
WO1999024577A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
EP1484405A1 (de) * 1997-11-10 2004-12-08 Statens Serum Institut Nukleinsäure- und polypeptidfragmente von M. Tuberculosis
EP0921397A1 (de) * 1997-12-08 1999-06-09 Kreatech Biotechnology B.V. Verfahren zum Nachweis einer Mycobacterium Spezies
WO1999051748A2 (en) * 1998-04-07 1999-10-14 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6183957B1 (en) * 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
EP1104456A1 (de) * 1998-08-10 2001-06-06 Chiron Corporation Genmanipulierte antigenpräsentierende zellen die eine antigengruppe präsentieren, und deren verwendungen
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
ES2326257T3 (es) 1999-05-04 2009-10-06 The University Of Medicine And Dentistry Of New Jersey Proteinas expresadas por mycobacterium tuberculosis y no por bcg y su utilizacion como reactivos diagnosticos y vacunas.
EP1517913B9 (de) * 1999-10-07 2007-08-29 Corixa Corporation Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
ATE442866T1 (de) 2000-06-20 2009-10-15 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US20040072262A1 (en) 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
WO2005077003A2 (en) * 2004-02-09 2005-08-25 Friedman Richard L Pili from mycobacterium tuberculosis
WO2006009838A2 (en) * 2004-06-17 2006-01-26 Beckman Coulter, Inc. Mycobacterium tuberculosis epitopes and methods of use thereof
KR101255870B1 (ko) 2004-11-16 2013-04-17 아에라스 글로벌 티비 백신 파운데이션 재조합 바이러스 벡터를 포함하는 다가 백신
PL2457926T3 (pl) 2005-04-29 2015-03-31 Glaxosmithkline Biologicals Sa Nowy sposób profilaktyki lub leczenia zakażenia m. tuberculosis
CN103123353B (zh) * 2007-12-28 2014-11-12 株式会社比尔生命 结核分歧杆菌复合群的免疫检出方法
SG182573A1 (en) 2010-01-27 2012-08-30 Glaxosmithkline Biolog Sa Modified tuberculosis antigens
WO2012080370A1 (en) 2010-12-14 2012-06-21 Glaxosmithkline Biologicals S.A. Mycobacterium antigenic composition
WO2013119763A1 (en) 2012-02-07 2013-08-15 Intuitive Biosciences, Inc. Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates
US20170305976A1 (en) 2014-10-23 2017-10-26 Qiagen Sciences, Llc Peptide composition and uses thereof
CN106008685A (zh) * 2016-05-18 2016-10-12 首都医科大学附属北京胸科医院 Trxc抗体识别的抗原多肽及其用途
CA3059408A1 (en) * 2016-09-22 2018-04-12 Pace Diagnostics, Inc Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis
EP3399312A1 (de) 2017-05-05 2018-11-07 Biomérieux Erkennungsverfahren einer zellulären immunantwort
EP4124862A1 (de) 2017-05-05 2023-02-01 bioMérieux Verfahren zum nachweis einer zellulären immunantwort
KR20220052937A (ko) * 2019-07-30 2022-04-28 디엔에이 스크립트 폴리(a) 및 폴리(u) 중합효소를 사용한 폴리뉴클레오타이드의 주형-부재 효소적 합성
CN111269856B (zh) * 2020-02-19 2021-11-30 首都医科大学附属北京胸科医院 一种分离和/或富集结核分枝杆菌的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
EP0419355B1 (de) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test

Also Published As

Publication number Publication date
DE69636075D1 (de) 2006-06-01
JPH11514217A (ja) 1999-12-07
CN1554664A (zh) 2004-12-15
WO1997009429A3 (en) 1997-07-17
CN1200146A (zh) 1998-11-25
WO1997009429A2 (en) 1997-03-13
MX9801687A (es) 1998-11-29
ATE324445T1 (de) 2006-05-15
EP0850305A2 (de) 1998-07-01
CA2230927A1 (en) 1997-03-13
EP2154248A1 (de) 2010-02-17
CN1154730C (zh) 2004-06-23
ES2378051T3 (es) 2012-04-04
EP0850305B1 (de) 2006-04-26
EP2154248B1 (de) 2011-10-26
AU7158796A (en) 1997-03-27
DK2154248T3 (da) 2012-01-30
PT2154248E (pt) 2012-01-16
CY2618B2 (de) 2012-10-24

Similar Documents

Publication Publication Date Title
ATE324445T1 (de) Verbindungen und verfahren zur diagnose von tuberkulose
WO1998053076A3 (en) Compounds for diagnosis of tuberculosis and methods for their use
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
NO20012812D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av chlamydiainfeksjon
ATE389020T1 (de) Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
WO1998042740A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
NZ518917A (en) Compounds and methods for treatment and diagnosis of chlamydial infection
NO20030252L (no) Forbindelser og fremgangsmåter for behandling og diagnostikk av klamydiainfeksjon
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
ATE157123T1 (de) Verfahren und vorrichtung zur amperometrischen diagnostischen analyse
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
EP1712629A3 (de) Verbindungen und Verfahren zur Diagnose von Tuberkulose
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
TH84254A (th) สารประกอบและวิธีสำหรับการวินิจฉัยวัณโรค
TH84254B (th) สารประกอบและวิธีสำหรับการวินิจฉัยวัณโรค
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2154248

Country of ref document: EP